Cutler Group’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,820
| Closed | -$83K | – | 1930 |
|
|
2020
Q3 | $83K | Buy |
1,820
+520
| +40% | +$23.7K | 0.01% | 730 |
|
|
2020
Q2 | $65K | Buy |
+1,300
| New | +$65K | ﹤0.01% | 772 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1655 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1641 |
|
|
2019
Q2 | – | Sell |
-1,400
| Closed | -$133K | – | 1737 |
|
|
2019
Q1 | $133K | Buy |
1,400
+1,300
| +1,300% | +$124K | 0.01% | 562 |
|
|
2018
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 1306 |
|
|
2018
Q3 | $8K | Sell |
100
-500
| -83% | -$40K | ﹤0.01% | 1317 |
|
|
2018
Q2 | $69K | Buy |
600
+50
| +9% | +$5.75K | 0.01% | 810 |
|
|
2018
Q1 | $44K | Buy |
+550
| New | +$44K | ﹤0.01% | 976 |
|
|
2017
Q4 | – | Sell |
-14
| Closed | – | – | 2294 |
|
|
2017
Q3 | $0 | Sell |
14
-186
| -93% | – | ﹤0.01% | 2621 |
|
|
2017
Q2 | $7K | Buy |
+200
| New | +$7K | ﹤0.01% | 2275 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 2947 |
|
|
2016
Q4 | – | Sell |
-100
| Closed | -$2K | – | 3005 |
|
|
2016
Q3 | $2K | Sell |
100
-4,200
| -98% | -$84K | ﹤0.01% | 2549 |
|
|
2016
Q2 | $94K | Buy |
4,300
+3,520
| +451% | +$76.9K | ﹤0.01% | 1041 |
|
|
2016
Q1 | $22K | Sell |
780
-2,000
| -72% | -$56.4K | ﹤0.01% | 1674 |
|
|
2015
Q4 | $91K | Buy |
+2,780
| New | +$91K | 0.01% | 1097 |
|